Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

BACKGROUND: Fluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients. METHODS: Fourteen clinical studies (six Phase II and e...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Byrne, Paul M., Jacques, Loretta, Goldfrad, Caroline, Kwon, Namhee, Perrio, Michael, Yates, Louisa J., Busse, William W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122018/
https://www.ncbi.nlm.nih.gov/pubmed/27881132
http://dx.doi.org/10.1186/s12931-016-0473-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122018/
https://www.ncbi.nlm.nih.gov/pubmed/27881132
http://dx.doi.org/10.1186/s12931-016-0473-x

Ejemplares similares